|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/06 | |
| A61K 31/4439 |
| (11) | Number of the document | 2900240 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13840379.5 |
| Date of filing the European patent application | 2013-09-20 | |
| (97) | Date of publication of the European application | 2015-08-05 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/060787 |
| Date | 2013-09-20 |
| (87) | Number | WO 2014/052171 |
| Date | 2014-04-03 |
| (30) | Number | Date | Country code |
| 201261705780 P | 2012-09-26 | US |
| (72) |
MAGUIRE, Courtney, K., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | CRYSTALLINE FORM OF A REVERSE TRANSCRIPTASE INHIBITOR |
| CRYSTALLINE FORM OF A REVERSE TRANSCRIPTASE INHIBITOR |